We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$30.7B
AUM Growth
+$2.2B
(+7.7%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
4.07%
Top 10 Holdings %
Top 10 Hldgs %
34.82%
Holding
2,753
New
46
Increased
1,356
Reduced
554
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$164M |
| 2 |
Microsoft
MSFT
|
+$96.1M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$95.4M |
| 4 |
Amazon
AMZN
|
+$84.3M |
| 5 |
Apple
AAPL
|
+$79.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$49.8M |
| 2 |
Texas Instruments
TXN
|
+$45.8M |
| 3 |
Adobe
ADBE
|
+$45.1M |
| 4 |
Chevron
CVX
|
+$42.9M |
| 5 |
Keysight
KEYS
|
+$32.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.54% |
| 2 | Financials | 15.58% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALX
2526
Alexander's
ALX
$1.36B
| $24.3K | ﹤0.01% |
108
| – | – |
|
2527
Hyster-Yale Materials Handling
HY
$656M
| $23.4K | ﹤0.01% |
336
| – | – |
|
2528
Coherus Oncology
CHRS
$201M
| $23.4K | ﹤0.01% |
13,534
-1,988
| -13% | -$4K |
|
2529
Biomea Fusion
BMEA
$92.1M
| $21.3K | ﹤0.01% |
4,744
| – | – |
|
2530
Arbutus Biopharma
ABUS
$913M
| $20.9K | ﹤0.01% |
6,780
-101
| -1% | -$303 |
|
|
THRD
2531
DELISTED
Third Harmonic Bio
THRD
| $20.4K | ﹤0.01% |
1,571
-32
| -2% | -$396 |
|
|
CNTA
2532
DELISTED
Centessa Pharmaceuticals
CNTA
| $20.2K | ﹤0.01% |
2,234
-33
| -1% | -$313 |
|
2533
Scilex Holding
SCLX
$48.2M
| $19.5K | ﹤0.01% |
289
-3
| -1% | -$127 |
|
2534
Ascendis Pharma A/S
ASND
$16.7B
| $19K | ﹤0.01% |
139
-3
| -2% | -$408 |
|
2535
Dole
DOLE
$1.23B
| $18.4K | ﹤0.01% |
1,506
| – | – |
|
2536
Mobileye
MBLY
$2.24B
| $17.7K | ﹤0.01% |
631
-3,057
| -83% | -$88.5K |
|
|
KALV
2537
DELISTED
KalVista Pharmaceuticals
KALV
| $16.9K | ﹤0.01% |
1,436
-64
| -4% | -$747 |
|
2538
Frontier Group Holdings
ULCC
$1.6B
| $16.7K | ﹤0.01% |
3,389
| – | – |
|
2539
908 Devices
MASS
$371M
| $16.2K | ﹤0.01% |
3,145
-495
| -14% | -$2.99K |
|
2540
Angi Inc
ANGI
$186M
| $16.2K | ﹤0.01% |
843
| – | – |
|
|
SLSR
2541
Solaris Resources
SLSR
$1.35B
| $15.9K | ﹤0.01% |
+5,710
| New | +$19.7K |
|
2542
AC Immune
ACIU
$237M
| $15.4K | ﹤0.01% |
3,851
-68
| -2% | -$225 |
|
2543
Fulcrum Therapeutics
FULC
$291M
| $15.3K | ﹤0.01% |
2,475
-7
| -0.3% | -$53 |
|
2544
ATN International
ATNI
$494M
| $15.3K | ﹤0.01% |
671
| – | – |
|
|
JKS
2545
JinkoSolar
JKS
$888M
| $15K | ﹤0.01% |
723
-77
| -10% | -$1.9K |
|
2546
uniQure
QURE
$3.19B
| $14.6K | ﹤0.01% |
3,260
-431
| -12% | -$2.1K |
|
2547
British American Tobacco
BTI
$124B
| $14.6K | ﹤0.01% |
472
+248
| +111% | +$7.53K |
|
2548
Codexis
CDXS
$163M
| $13.6K | ﹤0.01% |
4,386
-12,618
| -74% | -$40.5K |
|
2549
Pluri
PLUR
$20M
| $13.2K | ﹤0.01% |
2,276
-359
| -14% | -$2.02K |
|
|
DQ
2550
Daqo New Energy
DQ
$991M
| $12.9K | ﹤0.01% |
883
-49
| -5% | -$1.03K |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q2 2024 Portfolio in Review
As of Q2 2024, Zurich Cantonal Bank held 2,753 positions worth $30.7B, up 7.7% from $28.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Zurich Cantonal Bank deployed $1.25B of net new capital in Q2 2024, opening 46 new positions and adding to 1,356 existing holdings. Its largest new stake was GE Vernova: 126,606 shares worth $21.7M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $49.8M trimmed.
- Zurich Cantonal Bank's largest Q2 2024 buy was GE Vernova: 126,606 shares worth $21.7M.
- Zurich Cantonal Bank added most to UBS Group in Q2 2024, an estimated $164M increase.
- Zurich Cantonal Bank's biggest Q2 2024 reduction was Merck, cutting an estimated $49.8M.
- Zurich Cantonal Bank fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $21.3M.
- Zurich Cantonal Bank's ten largest holdings make up 35% of its $30.7B portfolio in Q2 2024.
- Zurich Cantonal Bank opened 46 new positions and closed 109 in Q2 2024.
- Zurich Cantonal Bank's portfolio value rose 7.7% quarter-over-quarter to $30.7B.
Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.